Developer docs
API playgroundTry for free, no card

Search company profiles

Indovax

Full company profile

uuid000bv6g

Namestring
Indovax
Websiteurl
indovax.com
Company typeenum
Private
Founded yearint
1986
Short descriptiontext

Indovax is a privately held Indian biologics manufacturer founded in 1986 and headquartered in Gurgaon, with 251–500 employees producing biological products for domestic or international markets across nearly four decades of continuous operation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersGurugram, India
HQ citystring
Gurugram
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
biologics manufacturing, vaccine manufacturing, biological products, immunobiological products, life sciences manufacturing
Industry2 codes
PRIMARYHLAMAEAL
Veterinary Vaccines (Biologics)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAKAI
Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO)
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Biologics Manufacturing
Social media profiles1 record
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Indovax is described as a manufacturer of biologics. The company develops, produces, and sells biological products, consistent with the "vax" suffix in its corporate name that is commonly associated with vaccine production. Specific product lines, technology platforms, and customer segments are not disclosed in the available source material because the company website is currently under scheduled maintenance.

Differentiator
Functional benefit
Problem solved
No data
Peers10 records
TypeBroad incumbent
Description

Phibro Animal Health is a US-listed animal health and nutrition company with biologics-adjacent capabilities, relevant as a comparable for capital-markets valuation benchmarking against a private biologics manufacturer.

TypeBroad incumbent
Description

Elanco is a major global animal health company with a biologics/vaccines franchise and is relevant as a public-market comparable for valuation triangulation against a private biologics manufacturer like Indovax.

TypeRegional player
Description

Vetoquinol is a European-headquartered animal health company with veterinary biologics capabilities and serves as a comparable mid-sized regional player for valuation benchmarking against Indovax.

TypeBroad incumbent
Description

Ceva is a global animal health company with a strong veterinary vaccines portfolio, particularly in poultry and swine, making it a comparable broad incumbent to Indovax in biologics manufacturing.

TypeDirect peer
Description

Hester Biosciences is an Indian veterinary vaccine and animal health products manufacturer with comparable scale and a poultry/livestock vaccine focus that closely overlaps with Indovax's biologics manufacturing profile.

TypeBroad incumbent
Description

Zoetis is the global leader in animal health and vaccines. As a broad incumbent in the biologics/veterinary vaccine category, it represents the dominant competitive benchmark and exit-multiple anchor for Indovax.

TypeDirect peer
Description

Indian Immunologicals is a Hyderabad-based biologics and vaccine manufacturer producing human and animal vaccines, making it the closest direct Indian peer to Indovax in biologics manufacturing focus and geography.

TypeEmerging player
Description

Biovac is an emerging-market vaccines and biologics manufacturer based in South Africa, comparable to Indovax as a regionally focused biologics platform serving emerging-market demand.

TypeOthers
Description

MSD Animal Health is a global animal vaccines and biologics incumbent and a direct category competitor to Indovax in the broader vaccine/biologics manufacturing space, though at far greater scale.

10Boehringer Ingelheim Animal Health
TypeBroad incumbent
Description

Boehringer Ingelheim's animal health business is a global veterinary biologics and vaccines leader and a relevant peer for understanding competitive dynamics and category multiples in Indovax's market.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Indovax

Biologics Manufacturingindovax.com

Indovax is a privately held Indian biologics manufacturer founded in 1986 and headquartered in Gurgaon, with 251–500 employees producing biological products for domestic or international markets across nearly four decades of continuous operation.

Indovax firmographics

Firmographics
Name
Indovax
Website
https://indovax.com
Company type
Private
Founded year
1986
Operating status
Operating
Headcount range
101–250 employees
Short description
Indovax is a privately held Indian biologics manufacturer founded in 1986 and headquartered in Gurgaon, with 251–500 employees producing biological products for domestic or international markets across nearly four decades of continuous operation.
Ownership category
akta.pro rank

Indovax industry classification

Industry
Product category
Biologics Manufacturing
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAMAEAL
Veterinary Vaccines (Biologics)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAKAI
Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO)

Keywords

  • Biologics manufacturing
  • Vaccine manufacturing
  • Biological products
  • Immunobiological products
  • Life sciences manufacturing

Where Indovax is headquartered

Location

Headquarters

HQ city
Gurugram
HQ country
India
HQ region
Asia

Markets served

Indovax business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing

Indovax product offering

Product offering

Core offering

Indovax is described as a manufacturer of biologics. The company develops, produces, and sells biological products, consistent with the "vax" suffix in its corporate name that is commonly associated with vaccine production. Specific product lines, technology platforms, and customer segments are not disclosed in the available source material because the company website is currently under scheduled maintenance.

Differentiator

Problem solved

Functional benefit

Companies that use Indovax

Customer profile

Ideal customer profiles1 record

Indovax technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Indovax competitors and assessment

Company assessment

Broad incumbents

  • Phibro Animal Health: Phibro Animal Health is a US-listed animal health and nutrition company with biologics-adjacent capabilities, relevant as a comparable for capital-markets valuation benchmarking against a private biologics manufacturer.
  • Elanco Animal Health: Elanco is a major global animal health company with a biologics/vaccines franchise and is relevant as a public-market comparable for valuation triangulation against a private biologics manufacturer like Indovax.
  • Ceva Santé Animale: Ceva is a global animal health company with a strong veterinary vaccines portfolio, particularly in poultry and swine, making it a comparable broad incumbent to Indovax in biologics manufacturing.
  • Zoetis: Zoetis is the global leader in animal health and vaccines. As a broad incumbent in the biologics/veterinary vaccine category, it represents the dominant competitive benchmark and exit-multiple anchor for Indovax.
  • Boehringer Ingelheim Animal Health: Boehringer Ingelheim's animal health business is a global veterinary biologics and vaccines leader and a relevant peer for understanding competitive dynamics and category multiples in Indovax's market.

Regional players

  • Vetoquinol: Vetoquinol is a European-headquartered animal health company with veterinary biologics capabilities and serves as a comparable mid-sized regional player for valuation benchmarking against Indovax.

Direct peers

  • Hester Biosciences: Hester Biosciences is an Indian veterinary vaccine and animal health products manufacturer with comparable scale and a poultry/livestock vaccine focus that closely overlaps with Indovax's biologics manufacturing profile.
  • Indian Immunologicals: Indian Immunologicals is a Hyderabad-based biologics and vaccine manufacturer producing human and animal vaccines, making it the closest direct Indian peer to Indovax in biologics manufacturing focus and geography.

Emerging players

  • Biovac: Biovac is an emerging-market vaccines and biologics manufacturer based in South Africa, comparable to Indovax as a regionally focused biologics platform serving emerging-market demand.

Others

  • MSD Animal Health: MSD Animal Health is a global animal vaccines and biologics incumbent and a direct category competitor to Indovax in the broader vaccine/biologics manufacturing space, though at far greater scale.

Market position

Customer concentration

Indovax social profiles

Digital presence

Indovax financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Indovax leadership team

Management profile

Number of profiles

Indovax funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Indovax M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Indovax

What does Indovax do?

Indovax is described as a manufacturer of biologics. The company develops, produces, and sells biological products, consistent with the "vax" suffix in its corporate name that is commonly associated with vaccine production. Specific product lines, technology platforms, and customer segments are not disclosed in the available source material because the company website is currently under scheduled maintenance.

When was Indovax founded?

Indovax was founded in 1986. It employs 101 to 250 people.

Where is Indovax based?

Indovax is headquartered in Gurugram, India, in the Asia region.

Who are Indovax's main competitors?

Broad incumbents on record are Phibro Animal Health, Elanco Animal Health, Ceva Santé Animale, Zoetis and Boehringer Ingelheim Animal Health. Vetoquinol is listed as a regional player. Direct peers are Hester Biosciences and Indian Immunologicals. Biovac is listed as an emerging player. MSD Animal Health is listed as an others.

Does Indovax have an API?

No public API is recorded for Indovax.

What industry is Indovax in?

Indovax's product category is Biologics Manufacturing. Its primary akta.pro industry code is HLAMAEAL, Veterinary Vaccines (Biologics), with a secondary code of HLAMAKAI, Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales